Low level of tonic interferon signalling is associated with enhanced susceptibility to SARS-CoV-2 variants of concern in human lung organoids.

Journal Information

Full Title: Emerg Microbes Infect

Abbreviation: Emerg Microbes Infect

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"flow cytometry data are available at http://flowrepository org/id/fr-fcm-z65r . data availability statement data included in this manuscript have been deposited in figshare at https://doi org/10 6084/m9 figshare 22266313 . data availability statement data included in this manuscript have been deposited in figshare"

Code Sharing
Evidence found in paper:

"Disclosure statement No potential conflict of interest was reported by the author(s)."

Evidence found in paper:

"We would like to thank R. Rosenke and D. Long for assistance with histology and ISH of hLOs, Craig Martens, Kimmo Virtaneva, and Kent Barbian for library preparation and RNA-sequencing, along with Justin Lack and Colton McNinch for helpful bioinformatics discussions. We also thank C. Bushmaker, at Bitterroot Health Hospital; A. Pekosz, Johns Hopkins Bloomberg School of Public Health, and M. Suthar, Emory University School of Medicine for contributing SARS-COV-2 isolates. Vero E6-TMPRSS2-T2A-ACE2 cells were obtained through BEI Resources, NIAID, NIH: Cercopithecus aethiops Kidney Epithelial Cells Expressing Transmembrane Protease, Serine 2 and Human Angiotensin-Converting Enzyme 2 (Vero E6-TMPRSS2-T2A-ACE2), RN-54970. This study was supported by the Intramural Research Program of NIAID, NIH."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025